
Ebenezer O. Sackey
Examiner (ID: 17838)
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1613, 1201, 1626, 1624, 1621 |
| Total Applications | 2086 |
| Issued Applications | 1598 |
| Pending Applications | 91 |
| Abandoned Applications | 399 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6258561
[patent_doc_number] => 20100029951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'Process for producing acrylonitrile compound'
[patent_app_type] => utility
[patent_app_number] => 12/588251
[patent_app_country] => US
[patent_app_date] => 2009-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9067
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20100029951.pdf
[firstpage_image] =>[orig_patent_app_number] => 12588251
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/588251 | Process for producing acrylonitrile compound | Oct 7, 2009 | Issued |
Array
(
[id] => 6378353
[patent_doc_number] => 20100081678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-01
[patent_title] => 'INDOLE COMPOUNDS AND THEIR USE AS RADIATION SENSITIZING AGENTS AND CHEMOTHERAPEUTIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/571425
[patent_app_country] => US
[patent_app_date] => 2009-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9405
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20100081678.pdf
[firstpage_image] =>[orig_patent_app_number] => 12571425
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/571425 | Indole compounds and their use as radiation sensitizing agents and chemotherapeutic agents | Sep 29, 2009 | Issued |
Array
(
[id] => 8834570
[patent_doc_number] => 08450326
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-28
[patent_title] => 'Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases'
[patent_app_type] => utility
[patent_app_number] => 12/564582
[patent_app_country] => US
[patent_app_date] => 2009-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40039
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12564582
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/564582 | Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases | Sep 21, 2009 | Issued |
Array
(
[id] => 8834570
[patent_doc_number] => 08450326
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-28
[patent_title] => 'Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases'
[patent_app_type] => utility
[patent_app_number] => 12/564582
[patent_app_country] => US
[patent_app_date] => 2009-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40039
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12564582
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/564582 | Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases | Sep 21, 2009 | Issued |
Array
(
[id] => 8834570
[patent_doc_number] => 08450326
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-28
[patent_title] => 'Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases'
[patent_app_type] => utility
[patent_app_number] => 12/564582
[patent_app_country] => US
[patent_app_date] => 2009-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40039
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12564582
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/564582 | Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases | Sep 21, 2009 | Issued |
Array
(
[id] => 8834570
[patent_doc_number] => 08450326
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-28
[patent_title] => 'Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases'
[patent_app_type] => utility
[patent_app_number] => 12/564582
[patent_app_country] => US
[patent_app_date] => 2009-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40039
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12564582
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/564582 | Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases | Sep 21, 2009 | Issued |
Array
(
[id] => 6375162
[patent_doc_number] => 20100075985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-25
[patent_title] => 'BENZO[D]ISOXAZOL-3-YL-PIPERAZIN DERIVATIVES USEFUL AS MODULATORS OF DOPAMINE D3 RECEPTORS'
[patent_app_type] => utility
[patent_app_number] => 12/560471
[patent_app_country] => US
[patent_app_date] => 2009-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8225
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20100075985.pdf
[firstpage_image] =>[orig_patent_app_number] => 12560471
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/560471 | Benzo[D]isoxazol-3-yl-piperazin derivatives useful as modulators of dopamine D3 receptors | Sep 15, 2009 | Issued |
Array
(
[id] => 6280946
[patent_doc_number] => 20100119622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-13
[patent_title] => '3H-BENZOOXAZOL-2-ONE MODULATORS OF D2 RECEPTOR AND/OR 5-HT1A RECEPTOR'
[patent_app_type] => utility
[patent_app_number] => 12/559649
[patent_app_country] => US
[patent_app_date] => 2009-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12390
[patent_no_of_claims] => 75
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20100119622.pdf
[firstpage_image] =>[orig_patent_app_number] => 12559649
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/559649 | 3H-BENZOOXAZOL-2-ONE MODULATORS OF D2 RECEPTOR AND/OR 5-HT1A RECEPTOR | Sep 14, 2009 | Abandoned |
Array
(
[id] => 8328888
[patent_doc_number] => 08236986
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-08-07
[patent_title] => 'Process for preparing acylsulfamoylbenzamides'
[patent_app_type] => utility
[patent_app_number] => 12/557727
[patent_app_country] => US
[patent_app_date] => 2009-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9794
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12557727
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/557727 | Process for preparing acylsulfamoylbenzamides | Sep 10, 2009 | Issued |
Array
(
[id] => 6177510
[patent_doc_number] => 20110178042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-21
[patent_title] => 'Hydroxamic Acid Derivatives Useful as Antibacterial Agents'
[patent_app_type] => utility
[patent_app_number] => 13/119484
[patent_app_country] => US
[patent_app_date] => 2009-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44304
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20110178042.pdf
[firstpage_image] =>[orig_patent_app_number] => 13119484
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/119484 | Hydroxamic acid derivatives useful as antibacterial agents | Aug 31, 2009 | Issued |
Array
(
[id] => 7696112
[patent_doc_number] => 20110230478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-22
[patent_title] => '4-Alkyl-substituted diaminopyrimidines'
[patent_app_type] => utility
[patent_app_number] => 13/061984
[patent_app_country] => US
[patent_app_date] => 2009-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42234
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0230/20110230478.pdf
[firstpage_image] =>[orig_patent_app_number] => 13061984
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/061984 | 4-Alkyl-substituted diaminopyrimidines | Aug 25, 2009 | Abandoned |
Array
(
[id] => 6368765
[patent_doc_number] => 20100074973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-25
[patent_title] => 'THIOXANTHENE MODULATORS OF DOPAMINE D2 RECEPTORS'
[patent_app_type] => utility
[patent_app_number] => 12/545121
[patent_app_country] => US
[patent_app_date] => 2009-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10383
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20100074973.pdf
[firstpage_image] =>[orig_patent_app_number] => 12545121
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/545121 | THIOXANTHENE MODULATORS OF DOPAMINE D2 RECEPTORS | Aug 20, 2009 | Abandoned |
Array
(
[id] => 9454634
[patent_doc_number] => 08715638
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-06
[patent_title] => 'Ethenyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections'
[patent_app_type] => utility
[patent_app_number] => 13/059199
[patent_app_country] => US
[patent_app_date] => 2009-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50318
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13059199
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/059199 | Ethenyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections | Aug 18, 2009 | Issued |
Array
(
[id] => 9762590
[patent_doc_number] => 08846915
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-30
[patent_title] => 'Process for the manufacture of rosuvastatin calcium using crystalline rosuvastatin ethyl ester'
[patent_app_type] => utility
[patent_app_number] => 13/261184
[patent_app_country] => US
[patent_app_date] => 2009-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4772
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13261184
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/261184 | Process for the manufacture of rosuvastatin calcium using crystalline rosuvastatin ethyl ester | Aug 16, 2009 | Issued |
Array
(
[id] => 6530153
[patent_doc_number] => 20100221221
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-02
[patent_title] => 'N-PHENYL-2-PYRIMIDINEAMINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 12/539091
[patent_app_country] => US
[patent_app_date] => 2009-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16468
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20100221221.pdf
[firstpage_image] =>[orig_patent_app_number] => 12539091
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/539091 | N-PHENYL-2-PYRIMIDINEAMINE DERIVATIVES | Aug 10, 2009 | Abandoned |
Array
(
[id] => 7580954
[patent_doc_number] => 20110294837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-01
[patent_title] => 'Aurora Kinase Modulators and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 13/058616
[patent_app_country] => US
[patent_app_date] => 2009-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20113
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0294/20110294837.pdf
[firstpage_image] =>[orig_patent_app_number] => 13058616
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/058616 | Aurora kinase modulators and methods of use | Aug 6, 2009 | Issued |
Array
(
[id] => 4465212
[patent_doc_number] => 07935836
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-03
[patent_title] => 'Compounds comprising a linear series of five fused carbon rings, and preparation thereof'
[patent_app_type] => utility
[patent_app_number] => 12/536705
[patent_app_country] => US
[patent_app_date] => 2009-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15901
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/935/07935836.pdf
[firstpage_image] =>[orig_patent_app_number] => 12536705
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/536705 | Compounds comprising a linear series of five fused carbon rings, and preparation thereof | Aug 5, 2009 | Issued |
Array
(
[id] => 6632123
[patent_doc_number] => 20100004479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-07
[patent_title] => 'PROCESSES FOR PRODUCING CARBONIC ESTER AND PRODUCING POLYCARBONATE'
[patent_app_type] => utility
[patent_app_number] => 12/512601
[patent_app_country] => US
[patent_app_date] => 2009-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10196
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20100004479.pdf
[firstpage_image] =>[orig_patent_app_number] => 12512601
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/512601 | Processes for producing carbonic ester and producing polycarbonate | Jul 29, 2009 | Issued |
Array
(
[id] => 4624486
[patent_doc_number] => 08003784
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-23
[patent_title] => 'Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same'
[patent_app_type] => utility
[patent_app_number] => 12/508679
[patent_app_country] => US
[patent_app_date] => 2009-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8046
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/003/08003784.pdf
[firstpage_image] =>[orig_patent_app_number] => 12508679
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/508679 | Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same | Jul 23, 2009 | Issued |
Array
(
[id] => 9977527
[patent_doc_number] => 09023838
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-05
[patent_title] => 'Crystalline form I rosuvastatin zinc salt'
[patent_app_type] => utility
[patent_app_number] => 13/383490
[patent_app_country] => US
[patent_app_date] => 2009-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5714
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13383490
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/383490 | Crystalline form I rosuvastatin zinc salt | Jul 23, 2009 | Issued |